Targeting the mTOR signaling pathway in neuroendocrine tumors - Wikidata - wikimedia - TriplyDB

Targeting the mTOR signaling pathway in neuroendocrine tumors

Targeting the mTOR signaling pathway in neuroendocrine tumors

http://www.wikidata.org/entity/Q26852089

about

Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management.Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing Biomarkers and novel agents in esophago-gastric cancer: are we making progress?Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Translational research in neuroendocrine tumors: pitfalls and opportunities.Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY.Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines.Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors.Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report.Molecular challenges of neuroendocrine tumors.Update in the Therapy of Advanced Neuroendocrine Tumors.Challenging Management of Neuroendocrine Tumor With Hepatic Metastasis and Carcinoid Heart Disease in a Child.Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.

P2860

Q35963760-A7B38B52-7735-41F5-8F90-B42E0A96421F Q37631597-A6633687-823A-4F00-BCB7-5352E4CA03C0 Q37698605-C18B4FB3-0E9F-4F40-8155-7F4D1ED7917C Q37702668-E8DD26D5-70FC-47D0-8CAE-95384B4DFB12 Q38575013-AACCE1E3-F767-4132-99EE-7F2F8992719B Q38743093-77ED05C3-2942-4169-9B6F-A263E844CCCA Q38849186-3BBBDBB8-A5A8-420B-A719-23C811B038CC Q38958002-0195BDC9-BD7F-460D-90DA-936FA2F7566B Q39246209-3152398B-E8B5-445A-ACC3-E1B78E4F5886 Q39546506-6772AFA2-5AA4-4C66-BD00-3EE85A03E640 Q39735943-BE53BCFD-BCEB-4C82-A167-9816B4E452FB Q40773502-11428996-94EA-4FD0-B587-466B5BBEC43D Q41194522-D16E4CC7-4760-4E44-A2C4-B74AEF18FDB0 Q41552378-762C09E6-FDDB-4CFD-95F8-91911345268D Q41712392-EFCA2E09-4970-42CC-831F-894ACC3E5AD3 Q42379480-E1AF4862-2A60-4724-9CEE-AB245054A2A7 Q45071563-FE9A6C98-0825-4A5C-8AE1-0C3C9965A4A9 Q47128709-FB22FCE9-31C4-4F2F-886D-1F6D693D9CD0 Q48519149-34C62409-B809-444E-9852-A87BFFC49E2F Q49875027-A6CFC87E-331E-45A6-A94B-E5D3C9CDAFE6 Q49970741-08855670-E730-4BC6-9ABB-C6C304FA77BB Q51366001-833D4B6B-6055-4363-B3A1-1592FD648A80 Q52934867-D2D5BE50-0AA2-417F-BE96-BAB72D54E976

P2860

Targeting the mTOR signaling pathway in neuroendocrine tumors

http://www.wikidata.org/entity/Q26852089

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeting the mTOR signaling pathway in neuroendocrine tumors

@ast

Targeting the mTOR signaling pathway in neuroendocrine tumors

@en

Targeting the mTOR signaling pathway in neuroendocrine tumors

@nl

type

label

Targeting the mTOR signaling pathway in neuroendocrine tumors

@ast

Targeting the mTOR signaling pathway in neuroendocrine tumors

@en

Targeting the mTOR signaling pathway in neuroendocrine tumors

@nl

prefLabel

Targeting the mTOR signaling pathway in neuroendocrine tumors

@ast

Targeting the mTOR signaling pathway in neuroendocrine tumors

@en

Targeting the mTOR signaling pathway in neuroendocrine tumors

@nl

P1433

Q26852089-577F6B86-163A-4F1C-818B-F0A11A6B4BD4

P1476

Q26852089-F1D7DC38-5C97-4156-9D12-12A3FDE77C62

P2093

Q26852089-794E6E55-6FF7-4F1F-A01C-9B9B875A6608

Q26852089-7B333AD4-D113-4571-9950-B73BD5DC7A82

P2860

Q26852089-09F2E4F5-59A3-494B-A645-CEDF0EA32189

Q26852089-1052B8A5-E6AD-4F1C-A511-9194FD114F92

Q26852089-112E253F-4750-4CCA-B38C-8ABB179D19F9

Q26852089-120A95EF-F34D-4A50-ABB8-B9A62ED6FB03

Q26852089-1265D33E-A9B1-4B9C-9921-2220B0CB5F14

Q26852089-13355C4D-9925-4051-AED4-E35B59DCA06D

Q26852089-152F2B16-8B79-4697-9E64-5AF1A201784A

Q26852089-17291274-2282-49ED-AD04-1DBF2A34DB5C

Q26852089-234BAF30-FF17-4C85-9FB4-C408A815CE38

Q26852089-271AA40B-591E-4850-915D-C893B0E9D24D

P2888

Q26852089-5761660D-FDF9-4255-87E7-BF9FE11B694E

P304

Q26852089-BAF5B4E9-0C84-4332-A00C-3873F06482B0

P31

Q26852089-9A8B9E3A-26FA-41D8-BCAC-7A95C1D9C09C

Q26852089-DD9E60CA-5374-4868-B8A9-9912E6E02D74

P356

Q26852089-AD5D0EA0-4FB6-433A-AC89-062FC22F7D67

P407

Q26852089-8A6DF552-F356-41AD-9D26-590CFC76E626

P433

Q26852089-FBEB3250-98F2-4182-AEAB-304DC72FFD3C

P478

Q26852089-6DD7B219-C7C9-4077-B06C-5066BAD55412

P577

Q26852089-1C43A9DC-A854-4FC2-950D-A839EF9EFBDD

Q26852089-9B8ED7C7-97CA-444F-8790-5BBF7A1B90AB

P5875

Q26852089-6AC13BA0-C75F-403D-8205-656D6D43F5D9

P6179

Q26852089-307D5CC1-D8E5-4F5E-BC2B-1C327072B236

P698

Q26852089-54260EA3-7C2A-483A-A22E-4D1306DC1711

P921

Q26852089-387413ED-06E5-4E0F-A2A7-C647E219E313

Q26852089-4727E1E6-0879-4E35-B71D-1981D666A581

Q26852089-7FE12476-49AC-432C-892E-90370787693B

P932

Q26852089-7F1C2CDD-7FB3-4089-BA14-FDCDF66C296E

P356

S11864-014-0294-4

P1433

Current Treatment Options in Oncology

P1476

Targeting the mTOR signaling pathway in neuroendocrine tumors

@en

P2093

Jennifer Chan

http://www.w3.org/2001/XMLSchema#string

Matthew Kulke

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

mTOR: from growth signal integration to cancer, diabetes and ageing

mTOR signaling in growth control and disease

Targeting the mTOR signaling network for cancer therapy

Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience

TOR signaling in growth and metabolism

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

P2888

s11864-014-0294-4

P304

365-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-014-0294-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264501350

http://www.w3.org/2001/XMLSchema#string

P6179

1039108022

http://www.w3.org/2001/XMLSchema#string

P698

25092520

http://www.w3.org/2001/XMLSchema#string

P921

neuroendocrine tumor

mechanism of action

P932

4147239

http://www.w3.org/2001/XMLSchema#string